Treatment of Digital Vasospastic Disease with the Calcium-entry Blocker Nifedipine
Overview
Authors
Affiliations
Eight patients with vasospastic disease of the digital arteries were treated with the calcium-entry blocker nifedipine (capsules), 10 mg t.i.d. and 20 mg t.i.d. The degree of cold-induced digital vasospasm after local cooling of the finger to 15 and 10 degrees C, measured by strain-gauge technique, was significantly decreased by nifedipine. The degree of reduction was dose-dependent. All patients improved symptomatically. The side-effects of the drug were minor but became more prominent when the dose was increased. We conclude that nifedipine is a useful agent in the treatment of digital vasospastic disease.
Controlled double blind trial of nisoldipine in the treatment of idiopathic Raynaud's phenomenon.
Gjorup T, Hartling O, Kelbaek H, Nielsen S Eur J Clin Pharmacol. 1986; 31(4):387-9.
PMID: 3816916 DOI: 10.1007/BF00613511.
Clinical and rheological effects of nifedipine in Raynaud's phenomenon.
Waller D, Challenor V, Francis D, Roath O Br J Clin Pharmacol. 1986; 22(4):449-54.
PMID: 3533127 PMC: 1401145. DOI: 10.1111/j.1365-2125.1986.tb02916.x.
Leppert J, Jonasson T, Nilsson H, Ringqvist I Cardiovasc Drugs Ther. 1989; 3(3):397-401.
PMID: 2535054 DOI: 10.1007/BF01858110.
Sorkin E, Clissold S, Brogden R Drugs. 1985; 30(3):182-274.
PMID: 2412780 DOI: 10.2165/00003495-198530030-00002.
Use of nifedipine in hypertension and Raynaud's phenomenon.
Kiowski W, Erne P, Buhler F Cardiovasc Drugs Ther. 1990; 4 Suppl 5:935-40.
PMID: 2076403 DOI: 10.1007/BF02018296.